Frank Follmann

Comparison of Tuberculin Skin Test and New Specific Blood Test in Tuberculosis Contacts

Inger Brock, Karin Weldingh, Frank Follmann et al. · American Journal of Respiratory and Critical Care Medicine · 2004 · 337 citations

Vaccination, Pulmonary Tuberculosis, Vaccine Development +15

Cationic Liposomes Formulated with Synthetic Mycobacterial Cordfactor (CAF01): A Versatile Adjuvant for Vaccines with Different Immunological Requirements

Else Marie Agger, Ida Rosenkrands, Jon Hansen et al. · PLoS ONE · 2008 · 287 citations · Full text

Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens

Niels Peter Hell Knudsen, Anja Weinreich Olsen, Cecilia Buonsanti et al. · Scientific Reports · 2016 · 229 citations · Full text

Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial

Sonya Abraham, Helene Bæk Juel, Peter Fibiger Bang et al. · The Lancet Infectious Diseases · 2019 · 190 citations

Vaccination, Mucosal Vaccination, Caf01 Liposomes +4

Decoration of Outer Membrane Vesicles with Multiple Antigens by Using an Autotransporter Approach

Maria H. Daleke-Schermerhorn, Tristan Félix, Zora Soprova et al. · Applied and Environmental Microbiology · 2014 · 133 citations · Full text